Advertisement

Adherence to Behavioral Therapy for Migraine: Knowledge to Date, Mechanisms for Assessing Adherence, and Methods for Improving Adherence

  • Alexandra Gewirtz
  • Mia Minen
Psychological and Behavioral Aspects of Headache and Pain (D. Buse, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Psychological and Behavioral Aspects of Headache and Pain

Abstract

Purpose of Review

In other disease states, adherence to behavioral therapies has gained attention, with a greater amount of studies discussing, defining, and optimizing adherence. For example, a meta-analysis formally discussed adherence in 25 studies of CBT for 11 different disorders, with only 6 of the 25 omitting addressing or defining adherence. Many studies have discussed the use of text messages, graph-based adherence rates, and email/telephone reminders to improve adherence. This paper examined the available literature regarding adherence to behavioral therapy for migraine as well as adherence to similar therapies in other disease states. The goal of this research is to apply lessons learned from adherence to behavioral therapy for other diseases in better understanding how we can improve adherence to behavioral therapy for migraine.

Recent Findings

Treatment for migraine typically includes both pharmacologic and non-pharmacologic therapies, including progressive muscle relaxation (PMR), cognitive behavioral therapy (CBT), and biofeedback. Behavioral therapies have been shown to significantly reduce headache frequency and intensity, but high attrition rates and suboptimal adherence can undermine their efficacy. Traditionally, adherence to behavioral therapy has been defined by self-report, including paper headache diaries and assignments. In person attendance has also been employed as a method of defining and monitoring adherence. With the advent of personal electronics, measurements of adherence have shifted to include electronic-based methods such as computer-based programs and mobile-based therapies. Furthermore, some studies have taken advantage of electronic methods such as email reminders, push notifications, and other mobile-based reminders to optimize adherence. The JITA-I, a novel method of engaging individual patient adherence, has also been suggested as a possible method to improve adherence by tailoring engagement with a mobile health app-based on patient input. These novel methods may be utilized in behavioral therapy for migraine for further optimizing adherence.

Summary

Few intervention studies to date have addressed the optimal ways to impact adherence to migraine behavioral therapy. Further research is required regarding adherence with behavioral therapies, specifically via mobile health interventions to better understand how to define and improve adherence via this novel forum. Once we are able to understand optimal methods of tracking adherence, we will be better equipped to understand the role of adherence in shaping outcomes for behavioral therapy in migraine.

Keywords

Adherence Behavioral therapy Migraine Prevention 

Notes

Compliance with Ethical Standards

Conflict of Interest

Mia Minen has funding from the National Center for Complementary and Integrative Health (NCCIH) K23 AT009706-01 and the American Academy of Neurology (AAN)-American Brain Foundation (ABF) Practice Research Training Fellowship. Alexandra Gewirtz declares no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Campbell J, Penzien D, Wall E. Evidence-based guidelines for migraine headache: behavioral and physical treatments. 2000.Google Scholar
  2. 2.
    Matchar DB, Harpole L, Samsa GP, et al. The headache management trial: a randomized study of coordinated care. Headache. 2008;48(9):1294–310.Google Scholar
  3. 3.
    Holroyd KA, Cottrell CK, O’Donnell FJ, et al. Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ. 2010;341:c4871.  https://doi.org/10.1136/bmj.c4871.PubMedCentralGoogle Scholar
  4. 4.
    Powers SW, Kashikar-Zuck SM, Allen JR, et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA. 2013;310(24):2622–30.  https://doi.org/10.1001/jama.2013.282533.PubMedCentralGoogle Scholar
  5. 5.
    Penzien DB, Rains JC, Andrasik F. Behavioral management of recurrent headache: three decades of experience and empiricism. Appl Psychophysiol Biofeedback. 2002;27(2):163–81.Google Scholar
  6. 6.
    Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754–62.Google Scholar
  7. 7.
    Schafer AM, Rains JC, Penzien DB, Groban L, Smitherman TA, Houle TT. Direct costs of preventive headache treatments: comparison of behavioral and pharmacologic approaches. Headache. 2011;51(6):1526.Google Scholar
  8. 8.
    Horwitz R. Adherence to treatment and health outcomes. Arch Intern Med. 1993;153(16):1863.Google Scholar
  9. 9.
    Seng EK, Rains JA, Nicholson RA, Lipton RB. Improving medication adherence in migraine treatment. Curr Pain Headache Rep. 2015;19(6):24–015–0498-8.  https://doi.org/10.1007/s11916-015-0498-8.Google Scholar
  10. 10.
    Claxton A, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296.Google Scholar
  11. 11.
    Minen MT, Torous J, Raynowska J, et al. Electronic behavioral interventions for headache: A systematic review. J Headache Pain. 2016;17:51–016-0608-y.  https://doi.org/10.1186/s10194-016-0608-y.Google Scholar
  12. 12.
    •• Ramsey RR, Ryan JL, Hershey AD, Powers SW, Aylward BS, Hommel KA. Treatment adherence in patients with headache: A systematic review. Headache. 2014;54(5):795–816.  https://doi.org/10.1111/head.12353. This was a study of adherence for children undergoing progressive muscle relaxation for migraine. Adherence in this study was defined by the number of correct “relaxation passwords of the day” as recorded on the individual child’s relaxation log. The study also found a significant relationship between adherence and number of headache free days.
  13. 13.
    Engel JM. Children’s compliance with progressive relaxation procedures for improving headache control. OTJR (Thorofare N J). 1993;13:219.Google Scholar
  14. 14.
    Wisniewski JJ, Genshaft JL, Mulick JA, Coury DL, Hammer D. Relaxation therapy and compliance in the treatment of adolescent headache. Headache. 1988;28:612.Google Scholar
  15. 15.
    Guibert MB, Firestone P, McGrath P, Goodman JT, Cunningham JS. Compliance factors in the behavioural treatment of headache in children and adolescents. Canadian Journal of Behavioural Science/Revue canadienne des sciences du comportement. 1990;22(1):37.Google Scholar
  16. 16.
    •• Minen MT, Azarchi S, Sobolev R, Shallcross A, Hapern A, Berk T, et al. Factors related to migraine patients' decisions to initiate behavioral migraine treatment following a headache specialist’s recommendations: a prospective observational study. In: Pain medicine; June 2018. This was a multi center randomized controlled trial for adults with symptoms of depression (with scores of ≥ 10 on a standardized questionnaire for depression) who were randomised to receive a commercially produced computerized Cognitive Behavioral Therapy (CBT) program or a free to use cCBT program in addition to standard of care. Participants adhered to self report of symptoms. The study found that a commercially available cCBT or free to use CBT was not superior to general practitioner standard of care.Google Scholar
  17. 17.
    Gilbody S, Littlewood E, Hewitt C, Brierley G, Tharmanathan P, Araya R, et al. Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trial. BMJ. 2015;351:5627.Google Scholar
  18. 18.
    Tassorelli C, Sances G, Allena M, Ghiotto N, Bendtsen L, Olesen J, et al. The usefulness and applicability of a basic headache diary before first consultation: results of a pilot study conducted in two centres. Cephalagia. 2008;28(10):1023.Google Scholar
  19. 19.
    Lipchik GL, Holroyd KA, Nash JM. Cognitive-behavioral management of recurrent headache disorders: a minimal-therapist-contact approach. In: Psychological approaches to pain management. 2nd ed. New York: Guilford Pubs; 2002. p. 356.Google Scholar
  20. 20.
    •• Kroon Van Diest AM, Ramsey R, Kashikar-Zuck S, et al. Treatment adherence in child and adolescent chronic migraine patients: results from the cognitive behavioral therapy and amitriptyline trial. Clin J Pain. 2017;33:892. This paper reviewed the pathophysiology, diagnosis, and management of migraine in children and adolescents. As part of the management section, the paper discusses relaxation techniques that are commonly employed in the armamentarium against pediatric and adolescent headache. The paper also discusses strategies commonly employed in the effort to improve patient adherence to relaxation techniques. Visual reminders to cue compliance, such as charts for self monitoring, are suggested as a possible tool.Google Scholar
  21. 21.
    Kabbouche MAGD. Management of migraine in adolescents. Neuropsychiatr Dis Treat. 2008;4(3):535.PubMedCentralGoogle Scholar
  22. 22.
    Faedda N, Cerutti R, Verdecchia P, Migliorini D, Arruda M, Guidetti V. Behavioral management of headache in children and adolescents. J Headache Pain. 2016;17(1):80.PubMedCentralGoogle Scholar
  23. 23.
    Ahern DK, Kreslake JM, Phalen JM. What is eHealth (6): perspectives on the evolution of eHealth research. J Med Internet Res. 2006;8(1):e4.PubMedCentralGoogle Scholar
  24. 24.
    Sorbi M, Mak S, Houtveen J, Kleiboer A, van Doornen L. Mobile web-based monitoring and coaching: feasibility in chronic migraine. J Med Internet Res. 2007;9(5):e38.PubMedCentralGoogle Scholar
  25. 25.
    Andersson G, Lundström P, Ström L. Internet-based treatment of headache: does telephone contact add anything? Headache. 2003;43:353.Google Scholar
  26. 26.
    Devineni TBE. A randomized controlled trial of an internet-based treatment for chronic headache. Behav Res Ther. 2005;43:277.Google Scholar
  27. 27.
    Ström L, Pettersson R, Andersson G. A controlled trial of self-help treatment of recurrent headache conducted via the internet. J Consult Clin Psychol. 2000;68:722.Google Scholar
  28. 28.
    Bromberg J, Wood ME, Black RA, Surette DA, Zacharoff KL, Chiauzzi EJ. A randomized trial of a web-based intervention to improve migraine self-management and coping. Headache. 2012;52(2):244–61.PubMedCentralGoogle Scholar
  29. 29.
    Dear BF, Titov N, Perry KN, Johnston L, Wootton BM, Terides MD, et al. The pain course: a randomised controlled trial of a clinician-guided internet-delivered cognitive behaviour therapy program for managing chronic pain and emotional well-being. Pain. 2013;154(6):942.Google Scholar
  30. 30.
    Hedborg K, Muhr C. Multimodal behavioral treatment of migraine: an internet-administered, randomized, controlled trial. Ups J Med Sci. 2011;116:169–86.PubMedCentralGoogle Scholar
  31. 31.
    Sorbi MJ, van der Vaart R. User acceptance of an internet training aid for migraine self-management. J Telemed Telecare. 2010;16(1):30.Google Scholar
  32. 32.
    Jahns RG. Jahns R-G. 500m people will be us- ing healthcare mobile applications in 2015 . Updated 2010. Accessed 06/12, 2018.Google Scholar
  33. 33.
    Bond DS, O’Leary KC, Thomas JG, et al. Can weight loss improve migraine headaches in obese women? Rationale and design of the WHAM randomized controlled trial. Contemp Clin Trials. 2013;35(1):133.PubMedCentralGoogle Scholar
  34. 34.
    Minen MT, Jalloh A, Ortega E, Powers SW, Sevick MA, Lipton RB. User design and experience preferences in a novel smartphone application for migraine management: a think aloud study of the RELAXaHEAD application. Pain Med. 2018.Google Scholar
  35. 35.
    Ramsey R, Holbein C, Powers S, Hershey A, Kabbouche MA, et al. A pilot investigation of a mobile phone application and progressive reminder system to improve adherence to daily prevention treatment in adolescents and young adults with migraine. Cephalalgia. 2018.Google Scholar
  36. 36.
    Stawarz K, Preist C, Tallon D, Wiles N, Coyle D. User experience of cognitive behavioral therapy apps for depression: An analysis of app functionality and user reviews. J Med Internet Res. 2018;20(6).Google Scholar
  37. 37.
    Donkin L, Christensen H, Naismith SL, Neal B, Hickie IB, Glozier N. A systematic review of the impact of adherence on the effectiveness of e-therapies. J Med Internet Res. 2011;13(3):e52.PubMedCentralGoogle Scholar
  38. 38.
    • Lindhiem O, Bennett CB, Rosen D, Silk J. Mobile technology boosts the effectiveness of psychotherapy and behavioral interventions: a meta-analysis. Behav Modif. 2015;39(6):785. This was a comprehensive systemic review and meta-analysis of internet delivered CBT (iCBT) for children and adolescents. The review included twenty five studies of iCBT for 11 different disorders. Treatment adherence and therapist time varied largely amongst sutudies. Twenty-four studies (N = 1882) were eventually included in the. There was a moderate between-group effect size of the iCBT group when compared with the waitlist, g = 0.62, 95% CI [0.41, 0.84], suggesting that iCBT for multiple different disorders can be successfully used.Google Scholar
  39. 39.
    Vigerland S, Lenhard F, Bonnert M, Lalouni M, Hedman E, et al. Internet-delivered cognitive behavior therapy for children and adolescents: a systematic review and meta-analysis. Clin Psychol Rev. 2016;50:1.Google Scholar
  40. 40.
    Tulbure BT, Szentagotai A, David O, et al. Internet-delivered cognitive-behavioral therapy for social anxiety disorder in Romania: a randomized controlled trial. PLoS One. 2015;10(5):e0123997.PubMedCentralGoogle Scholar
  41. 41.
    Patrick K, Raab F, Adams MA, Dillon L, Zabinski M, Rock CL, et al. Text message-based intervention for weight loss: randomized controlled trial. J Med Internet Res. 2009;11(1):e1.PubMedCentralGoogle Scholar
  42. 42.
    Kim HS, Yoo YS, Shim HS. Effects of an internet-based intervention on plasma glucose levels in patients with type 2 diabetes. J Nurs Care Qual. 2005;20(4):335.Google Scholar
  43. 43.
    Rodgers A, Corbett T, Bramley D, Riddell T, Wills M, Lin R, et al. Do u smoke after txt? Results of a randomised trial of smoking cessation using mobile phone text messaging. Tob Control. 2005;14(4):255.PubMedCentralGoogle Scholar
  44. 44.
    Ye Y, Chen N, Chen J, et al. Internet-based cognitive–behavioural therapy for insomnia (ICBT-i): a meta-analysis of randomised controlled trials. BMJ Open. 2016;6(11):E010707.PubMedCentralGoogle Scholar
  45. 45.
    Espie CA, Kyle SD, Williams C, et al. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep. 2012;35(6):769.PubMedCentralGoogle Scholar
  46. 46.
    Push notification. https://searchmobilecomputing.techtarget.com/definition/push-notification. Updated 2016. Accessed 06/01, 2018.
  47. 47.
    Bakker D, Kazantzis N, Rickwood D, Rickard N. Mental health smartphone apps: review and evidence-based recommendations for future developments. JMIR Mental Health. 2016;3(1):e7.PubMedCentralGoogle Scholar
  48. 48.
    Jones K, Lekhak N, Kaewluang N. Using mobile phones and short message service to deliver self-management interventions for chronic conditions: a meta-review. Worldviews Evid-Based Nurs. 2014;11(2):81.Google Scholar
  49. 49.
    •• Nahum-Shani I, Smith SN, Spring BJ, Collins LM, Witkiewitz K, Tewari A, et al. Just-in-time adaptive interventions (JITAIs) in mobile health: key components and design principles for ongoing health behavior support. Ann Behavioral Med. 2018;52(6):446. This was a randomized clinical trial involving 5 residential programs for patients meeting the criteria for DSM-IV alcohol dependence (n = 349). Patients were randomized to usual treatment (n = 179) or usual treatment plus a smartphone (n = 170) with the Addiction-Comprehensive Health Enhancement Support System (A-CHESS) application, designed to improve care for alcohol dependence. Patients in the A-CHESS group had significantly fewer risky drinking days than did the control patients (mean difference, 1.37; 95% CI, 0.46-2.27; P = .003).Google Scholar
  50. 50.
    Gustafson DH, McTavish FM, Chih M-Y, et al. A smartphone application to support recovery from alcoholism: a randomized clinical trial. JAMA psychiatry. 2014;71(5):566.PubMedCentralGoogle Scholar
  51. 51.
    Ben-Zeev D, Brenner CJ, Begale M, Duffecy J, Mohr DC, Mueser KT. Feasibility, acceptability, and preliminary efficacy of a smartphone intervention for schizophrenia. Schizophr Bull. 2014;40(6):1244.PubMedCentralGoogle Scholar
  52. 52.
    Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc. 2013;53(2):172.Google Scholar
  53. 53.
    Boulos MNK, Brewer AC, Karimkhani C, Buller DB, Dellavalle RP. Mobile medical and health apps: State of the art, concerns, regulatory control and certification. Online Journal of Public Health Informatics. 2014;5(3229).Google Scholar
  54. 54.
    Dantzig S, Geleijnse G, Halteren AT. Toward a persuasive mobile application to reduce sedentary behavior. Pers Ubiquit Comput. 2013;17(6):1237–46.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Alexandra Gewirtz
    • 1
  • Mia Minen
    • 2
  1. 1.New York Presbyterian- Weill CornellNew YorkUSA
  2. 2.NYU School of Medicine New YorkUSA

Personalised recommendations